Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 182 Total
ARES - Ares Management Corp - Stock Price Chart
TickerARES [NYSE]
CompanyAres Management Corp
CountryUSA
IndustryAsset Management
Market Cap26.04BEPS (ttm)2.43
P/E55.36EPS this Y25.71%
Forward P/E21.89EPS next Y34.06%
PEG2.09EPS past 5Y52.32%
P/S6.55EPS next 5Y26.50%
P/B13.55EPS Q/Q47.98%
Dividend2.79%Sales Q/Q20.39%
Insider Own15.18%Inst Own81.65%
Insider Trans-17.23%Inst Trans0.95%
Short Float1.89%EarningsMay 02/b
Analyst Recom2.07Target Price143.82
Avg Volume1.10M52W Range77.97 - 139.48
Ares Management Corp. engages in the provision of investment and consultancy services. It operates through the following segments: Credit Group, Private Equity Group, Real Assets Group, Secondaries Group, and Other. The Credit Group segment includes the management of strategies across the liquid and illiquid spectrum, direct lending, and Asia-Pacific. The Private Equity Group segment involves the categorization of investment strategies as corporate, special opportunities, and Asia-Pacific. The Real Assets Group segment focuses on equity and debt strategies across infrastructure investments. The Secondaries Group segment consists of investment in secondary markets, alternative asset class strategies, private equity, real estate, infrastructure, and credit. The company was founded by Michael J. Arougheti, David B. Kaplan, John H. Kissick, Antony P. Ressler, and Bennett Rosenthal in 1997 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RESSLER ANTONY PCo-Founder & Exec. ChairmanApr 17 '24Sale131.51143,56918,880,9870Apr 19 06:27 PM
RESSLER ANTONY PCo-Founder & Exec. ChairmanApr 16 '24Sale130.29159,86020,827,9320Apr 16 09:37 PM
RESSLER ANTONY PCo-Founder & Exec. ChairmanApr 15 '24Sale129.6094,69712,273,1630Apr 16 09:37 PM
Rosenthal BennettCo-Founder & Chairman of PEGApr 15 '24Sale129.7250,0006,485,8480Apr 16 09:38 PM
RESSLER ANTONY PCo-Founder & Exec. ChairmanApr 12 '24Sale131.97114,49215,109,0660Apr 12 08:54 PM
ARW - Arrow Electronics Inc. - Stock Price Chart
TickerARW [NYSE]
CompanyArrow Electronics Inc.
CountryUSA
IndustryElectronics & Computer Distribution
Market Cap6.62BEPS (ttm)15.79
P/E7.77EPS this Y-30.83%
Forward P/E7.68EPS next Y34.92%
PEG-EPS past 5Y14.36%
P/S0.20EPS next 5Y-10.00%
P/B1.14EPS Q/Q-37.52%
Dividend-Sales Q/Q-15.81%
Insider Own0.62%Inst Own103.17%
Insider Trans-1.22%Inst Trans-3.30%
Short Float3.93%EarningsMay 02/b
Analyst Recom3.22Target Price119.84
Avg Volume523.82K52W Range108.51 - 147.42
Arrow Electronics, Inc. engages in the provision of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It operates under the Global Components Business and Global Enterprise Computing Solutions (Global ECS) segments. The Global Components segment focuses on the marketing and distribution of electronic components enabled by a comprehensive range of value-added capabilities and services. The Global ECS segment is involved in providing comprehensive computing solutions and services. The company was founded by Robert W. Wentworth and John C. Waddell in 1935 and is headquartered in Centennial, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jean-Claude Carine LamercieSVP, CLO & SecretaryMar 05 '24Sale121.001,495180,89515,271Mar 06 11:24 AM
Marano Richard JohnPresident, Global ComponentsFeb 28 '24Sale116.461,900221,27412,108Feb 29 03:05 PM
Cho Yun SungVP, Corp. Cont., & CAOFeb 23 '24Sale117.2273986,6261,389Feb 26 11:23 AM
Kerins Sean JPresident and CEODec 28 '23Option Exercise56.717,043399,40975,887Dec 29 05:04 PM
HAMILTON GAILDirectorMay 30 '23Sale127.811,419181,362101Jun 01 06:26 PM
ATUS - Altice USA Inc - Stock Price Chart
TickerATUS [NYSE]
CompanyAltice USA Inc
CountryUSA
IndustryTelecom Services
Market Cap935.05MEPS (ttm)0.12
P/E17.55EPS this Y87.27%
Forward P/E14.85EPS next Y-38.58%
PEG-EPS past 5Y35.28%
P/S0.10EPS next 5Y-0.20%
P/B-EPS Q/Q39.20%
Dividend-Sales Q/Q-2.85%
Insider Own55.67%Inst Own51.03%
Insider Trans0.00%Inst Trans2.98%
Short Float11.87%EarningsMay 02/b
Analyst Recom2.95Target Price3.04
Avg Volume3.99M52W Range1.75 - 3.82
Altice USA, Inc. engages in the provision of broadband, pay television, telephony services, proprietary content, and advertising services. Its brands include Optimum, Suddenlink, Optimum Mobile, Altice Business, News 12 Networks, Cheddar News, a4 Advertising, and i24 News. The company was founded by Patrick Drahi in 2001 and is headquartered in Long Island City, NY.
AUPH - Aurinia Pharmaceuticals Inc - Stock Price Chart
TickerAUPH [NASD, RUT]
CompanyAurinia Pharmaceuticals Inc
CountryCanada
IndustryBiotechnology
Market Cap739.41MEPS (ttm)-0.55
P/E-EPS this Y100.31%
Forward P/E11.71EPS next Y26394.72%
PEG-EPS past 5Y6.35%
P/S4.21EPS next 5Y-
P/B1.97EPS Q/Q-2.02%
Dividend-Sales Q/Q58.59%
Insider Own11.59%Inst Own36.34%
Insider Trans-1.92%Inst Trans8.87%
Short Float9.01%EarningsMay 02/b
Analyst Recom1.75Target Price10.57
Avg Volume2.09M52W Range4.71 - 12.43
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greenleaf PeterChief Executive OfficerMar 06 '24Sale5.60126,981711,0941,522,114Mar 07 04:46 PM
Robertson Stephen P.EVP, General CounselMar 06 '24Sale5.6057,745323,372443,824Mar 07 04:41 PM
Donley Matthew MaxwellEVP, Ops & StrategyMar 06 '24Sale5.5140,665224,064584,072Mar 07 04:43 PM
Miller Joseph MChief Financial OfficerMar 06 '24Sale5.6034,811194,942495,928Mar 07 04:44 PM
Habig Scott MichaelChief Commercial OfficerMar 06 '24Sale5.6017,77799,551474,587Mar 07 04:42 PM
AVNS - Avanos Medical Inc - Stock Price Chart
TickerAVNS [NYSE, RUT]
CompanyAvanos Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap910.60MEPS (ttm)-1.32
P/E-EPS this Y33.66%
Forward P/E10.65EPS next Y34.38%
PEG-EPS past 5Y-
P/S1.29EPS next 5Y6.30%
P/B0.74EPS Q/Q-37.35%
Dividend-Sales Q/Q-20.32%
Insider Own2.27%Inst Own98.91%
Insider Trans-0.71%Inst Trans-0.42%
Short Float2.59%EarningsMay 02/b
Analyst Recom2.67Target Price23.50
Avg Volume244.50K52W Range17.24 - 29.73
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holbrook KerrSVP, Chief Commercial OfficerMar 18 '24Option Exercise0.002,531089,727Mar 19 04:10 PM
Greiner MichaelSVP - Chief Financial OfficerMar 18 '24Option Exercise0.004,2190155,714Mar 19 04:11 PM
Woody Joseph FralinChief Executive OfficerMar 18 '24Option Exercise0.0015,8210453,810Mar 19 04:09 PM
Greiner MichaelSVP - Chief Financial OfficerMar 14 '24Sale19.128,000152,980151,495Mar 15 11:40 AM
Shimer Julie AnnDirectorMar 11 '24Buy19.855009,92550,090Mar 11 05:15 PM
AXGN - Axogen Inc. - Stock Price Chart
TickerAXGN [NASD, RUT]
CompanyAxogen Inc.
CountryUSA
IndustryMedical Devices
Market Cap256.96MEPS (ttm)-0.51
P/E-EPS this Y15.69%
Forward P/E33.60EPS next Y222.09%
PEG-EPS past 5Y3.44%
P/S1.62EPS next 5Y-
P/B2.65EPS Q/Q29.38%
Dividend-Sales Q/Q18.69%
Insider Own6.05%Inst Own74.24%
Insider Trans-4.71%Inst Trans4.16%
Short Float4.07%EarningsMay 02/b
Analyst Recom1.00Target Price13.67
Avg Volume374.25K52W Range3.45 - 10.83
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm's products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scopelianos AngeloChief R&D OfficerMar 21 '24Option Exercise0.002,500058,604Mar 25 09:37 PM
Zaderej Karen L.CEOMar 21 '24Sale7.6839,280301,6701,124,565Mar 25 09:43 PM
Scopelianos AngeloChief R&D OfficerMar 21 '24Sale7.686,88152,84652,999Mar 25 09:37 PM
Donovan Michael PatrickVP OperationsMar 21 '24Sale7.686,03346,33337,992Mar 25 09:22 PM
DeVinney Erick WayneChief Innovation OfficerMar 21 '24Sale7.684,57835,159165,661Mar 25 09:40 PM
BAX - Baxter International Inc. - Stock Price Chart
TickerBAX [NYSE, S&P 500]
CompanyBaxter International Inc.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap18.75BEPS (ttm)-0.45
P/E-EPS this Y11.56%
Forward P/E11.49EPS next Y10.76%
PEG-EPS past 5Y-
P/S1.25EPS next 5Y4.07%
P/B2.23EPS Q/Q39.78%
Dividend3.30%Sales Q/Q-0.05%
Insider Own0.70%Inst Own91.77%
Insider Trans-1.78%Inst Trans0.70%
Short Float1.92%EarningsMay 02/b
Analyst Recom2.47Target Price44.92
Avg Volume3.63M52W Range31.01 - 50.21
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Option Exercise37.1764,4882,397,019206,778Mar 05 04:15 PM
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Sale40.6164,4882,618,858142,290Mar 05 04:15 PM
BBIO - BridgeBio Pharma Inc - Stock Price Chart
TickerBBIO [NASD, RUT]
CompanyBridgeBio Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap5.19BEPS (ttm)-3.95
P/E-EPS this Y11.18%
Forward P/E-EPS next Y13.65%
PEG-EPS past 5Y-13.29%
P/S558.17EPS next 5Y-
P/B-EPS Q/Q-4.61%
Dividend-Sales Q/Q-6.68%
Insider Own24.73%Inst Own70.54%
Insider Trans-0.41%Inst Trans2.45%
Short Float10.70%EarningsMay 02/b
Analyst Recom1.38Target Price49.25
Avg Volume1.71M52W Range12.75 - 44.32
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scott Randal W.DirectorMar 01 '24Sale34.002,50085,0006,500Mar 05 04:00 PM
Valantine HannahDirectorFeb 15 '24Option Exercise8.452,91524,6324,679Feb 20 04:03 PM
Valantine HannahDirectorFeb 15 '24Sale37.752,915110,0411,764Feb 20 04:03 PM
Valantine HannahDirectorJan 16 '24Option Exercise8.452,91524,6324,679Jan 18 04:10 PM
Valantine HannahDirectorJan 16 '24Sale37.972,915110,6831,764Jan 18 04:10 PM
BCE - BCE Inc - Stock Price Chart
TickerBCE [NYSE]
CompanyBCE Inc
CountryCanada
IndustryTelecom Services
Market Cap30.10BEPS (ttm)1.69
P/E19.56EPS this Y-6.75%
Forward P/E14.36EPS next Y3.33%
PEG7.52EPS past 5Y-6.75%
P/S1.65EPS next 5Y2.60%
P/B2.40EPS Q/Q-27.91%
Dividend8.88%Sales Q/Q0.20%
Insider Own0.07%Inst Own43.74%
Insider Trans0.00%Inst Trans-0.44%
Short Float1.71%EarningsMay 02/b
Analyst Recom2.67Target Price37.00
Avg Volume2.80M52W Range31.82 - 48.29
BCE, Inc. is a telecommunications and media company, which provides communication services to residential, business, and wholesale customers. It operates through the Bell Communication and Technology Services (Bell CTS) and bell media segments. The Bell CTS segment provides a wide range of communication products and services to consumers, businesses and government customers across Canada. The Bell Media segment includes conventional, specialty and pay television, digital media, radio broadcasting services, and out-of-home advertising services. The company was founded on February 25, 1970 and is headquartered in Verdun, Canada.
BCYC - Bicycle Therapeutics Plc ADR - Stock Price Chart
TickerBCYC [NASD]
CompanyBicycle Therapeutics Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap1.05BEPS (ttm)-5.15
P/E-EPS this Y1.42%
Forward P/E-EPS next Y-7.13%
PEG-EPS past 5Y-12.36%
P/S38.70EPS next 5Y-
P/B2.82EPS Q/Q-14.85%
Dividend-Sales Q/Q67.58%
Insider Own1.19%Inst Own87.34%
Insider Trans-5.09%Inst Trans2.39%
Short Float7.06%EarningsMay 02/b
Analyst Recom1.25Target Price43.20
Avg Volume393.51K52W Range12.54 - 28.91
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hannay Michael Charles FergusoCHIEF PROD & SUPPLY CHAIN OFFApr 11 '24Sale22.492575,78022,891Apr 12 04:30 PM
Lee KevinCHIEF EXECUTIVE OFFICERApr 03 '24Sale23.813,15875,192387,270Apr 05 04:30 PM
Skynner MichaelCHIEF TECHNOLOGY OFFICERApr 03 '24Sale23.8195522,73994,884Apr 05 04:30 PM
Milnes AlistairCHIEF OPERATING OFFICERApr 03 '24Sale23.8195522,73972,241Apr 05 04:30 PM
Crockett NigelCHIEF BUSINESS OFFICERApr 03 '24Sale23.8195522,73947,761Apr 05 04:30 PM
12345671019